+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

The manufacturing of high potent medicines has provided many challenges in terms of safe production, containment and handling due to their toxic nature. But due to changing strategies and supportive regulatory framework to protect patent infringement, pharmaceutical companies are now focusing on commercialization and development of the high potent medicines to build their pipeline of products.

While most of the highly potent drugs under development are for oncology treatments, there are also new advances in high potent compounds manufacturing particularly antibody-drug conjugates (ADC’s) which are the fastest growing segment as they deliver the cytotoxic drugs to the targeted cells.

MarketsandMarkets is proud to announce The High Potent Medicines Conference to be held on 6th-7th June 2017 in Berlin, Germany. The conference aims to focus on sharing the current market trends, technological advancements and future challenges in the high potent medicines industry where leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.

Key Highlights

  • Process validation considerations and scale-up in high potent API production
  • Strategies for effective management of HPAPI supply chain
  • ADC’s requirements on high containment processing
  • Validation of cleaning procedures to avoid cross contamination
  • Containment and safety of highly potent API's
  • Managing cleaning validation in API small molecules
  • Linking PDEs, OELs and Banding

conference Registration Form



Industry Delegate €1300
Solution Provider Delegate€1900


Key Highlights

  • Process validation considerations and scale-up in high potent API production
  • Strategies for effective management of HPAPI supply chain
  • ADC’s requirements on high containment processing
  • Validation of cleaning procedures to avoid cross contamination
  • Containment and safety of highly potent API's
  • Managing cleaning validation in API small molecules
  • Linking PDEs, OELs and Banding

Who Should Attend ?

From pharmaceutical and Biopharmaceutical manufacturing:

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

  • Research & Development
  • Manufacturing/Operations/Production
  • Maintenance
  • Engineering
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer
  • Environmental, Health & Safety (HSE)
  • Occupational Toxicology
  • Industrial Hygiene
  • New Products
  • Product Quality
  • Regulatory
  • Validation
  • Formulation Development
  • External Supply

Why attend?

  • Utilizing the best practices to ensure safe and efficient production of high potent medicines
  • Training sessions on complex high potent compounds handling and containment issues
  • Understanding the updated regulatory guidelines in the HPAPI process
  • Implementing response plans to react to an unplanned event
  • Knowing the outsourcing strategies to effectively build a reliable supply chain

Advisory Panel


  • Ester Lovšin Barle

    Head, Health Hazard Assessment 
    Novartis, Switzerland

  • Juergen Knoebel

    Head Small Molecules Quality Operations, 
    F. Hoffman La Roche AG, Switzerland


  • Ester Lovšin Barle

    Head, Health Hazard Assessment, Novartis, Switzerland
  • Juergen Knoebel

    Head Small Molecules Quality Operations, F.Hoffmann La Roche AG, Switzerland
  • Jason Hamm

    Director, Chemical Development Operations, Bristol-Myers Squibb, USA
  • Martin Butschies

    Head of Laboratory, Boehringer Ingelheim, Germany
  • Helena Hemming

    Senior Toxicologist AstraZeneca, Sweden
  • Pascal Drago

    Principal Technical Manager, Validation & Operations (PTQSP) F.Hoffmann La Roche AG, Switzerland
  • Timothy Briggs

    Chair Professional Standards Committee Leeds Beckett University, UK
  • Jorge Guerreiro

    Facilities Manager, R&D, Hovione, Portugal
  • Maxime Lefebvre

    Head of Department Pilot Plant, Oril Industrie-Servier, France
  • Martin Axon

    Principal Occupational Hygienist, SafeBridge Europe, UK
  • Claudio Salvagnini

    Sales Director, Minakem High Potent, Belgium
  • Karina Versyck

    Lead, Global Cleaning API Platform, Janssen Pharmaceuticals, Belgium
  • Richard Denk

    Head Sales Containment, SKAN AG, Switzerland


Silver Sponsor


Minakem High Potent (MHP) 

More than 40 years experience in Highly Potent compounds
High containment systems down to OEB class 5, OEL < 0.1μg / m3 / shift
FDA, GMP and EHS full compliance
Broad range of chemical expertise both on site and in the MINAFIN worldwide network of Fine Chemicals R&D laboratories and plants.


ESCOEsco Pharma
Esco Pharma is a leading manufacturer of High containment and isolation systems with a global manufacturing footprint spanning US, Europe and Asia. Esco design and manufacture Potent, Aseptic and Downflow booth containment systems, along with a range of Laboratory equipment, Biological safety cabinets, laminar flow benches, fume hoods and a range of analytical equipment. As a division of the Esco Group, Esco Pharma benefits from Esco's heritage in clean air and containment technologies dating back to 1978.

MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities

for sponsors and exhibitors.


All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation / workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

 For sponsorship opportunities please contact us at events@marketsandmarkets.com


All Poster presentations will take place in breaks and alongside the breakout sessions of the congress.  All the presentation will be displayed in a dedicated area along with accepted posters from both industry & vendor delegates.

To present a poster the presenter should be registered as a delegate and the poster space will be assigned on a first come first basic (Subjected to successful registration & space availability)In order to present a poster at the forum you need to be registered as a delegate.

Please note that there is limited space available and posters space is assigned on a first come first served basis (subject to checks and successful registration).

Posters should be presented as A0 or US equivalent, size E (841mm x 1189mm or 34 x 44 inches respectively) in portrait orientation.

Poster presentations are available to registered delegates only.

For further details and requirements please contact:

Email: events@marketsandmarkets.com
Tel:+91 20 6708 0285

Industry and Solution Provider delegates€99

Posters Submission Form



Bio DeutschlandBIO Deutschland (Biotechnology-Industry-Organisation Deutschland e. V.)

BIO Deutschland is the sector association of the German biotechnology industry and has set itself the objective of supporting and promoting the development of an innovative economic sector based on modern biosciences. The Berlin-based association currently has about 340 members and is run by a board of ten members consisting of CEOs and managing directors of biotechnology companies. 

The member companies and their experts are organised in working groups that deal with a variety of topics such as regulatory policy, diagnostics, finance and taxation, health policy, industrial bioeconomy, entrepreneurship or technology transfer. Using a wide range of political initiatives, BIO Deutschland lobbies for improvements to the legal parameters for innovative small and medium-sized enterprises. The association is also very active in a broad range of events with the aim of providing biotechnology with a platform for discussion and interaction.

European Biotechnology NetworkEuropean Biotechnology Network

The European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe. The non-profit organisation brings research groups, universities, SMEs, large companies and indeed all actors in biotechnology together to build and deliver partnerships.The primary goal of the European Biotechnology Network is to improve cooperation in the fields of biotechnology and the other life sciences, primarily between the 28 member states of the European Union, Switzerland and Norway.

BioPharmaChem IrelandBioPharmaChem Ireland

BioPharmaChem Ireland is the biopharma, pharma and chemicals sector association of Ibec. Representing multinational and indigenous members, our strategy is to ensure Ireland becomes the global centre of excellence for innovation and development. We aim to achieve this through our advocacy work with national and international agencies or governments, tackling specific issues affecting the industry through our working groups and building a future talent pipeline.

Swiss Biotech AssociationThe Swiss Biotech Association (SBA)

The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.
Since 2014 the SBA is consortia member of Ecobiofor, a FP7 project with researcher organizations, biotech and paint associations and paints SME's developing bio-based solvents using green chemistry and biotechnology.

AsebioASEBIO-Spanish Bioindustry Association

ASEBIO-Spanish Bioindustry Association brings together companies, associations, foundations, universities, research and technology centres that engage in activities directly or indirectly related to biotechnology in Spain. Since 1999 ASEBIO has been a meeting point and platform for the promotion of organisations interested in stimulating the national biotechnology sector.

Science Marketplace

Science Marketplace

Science Marketplace is a free platform which aims to facilitate all sorts of scientific exchanges including collaborations, services, jobs, studentships and conferences. In other words, to provide an online marketplace for scientists of all fields.  Please post your expertise to establish new collaborations, showcase your company or university services, advertise jobs, conferences, etc.



The High Potent Medicines Conference 
will be held at the Steigenberger Hotel in Berlin, Germany.

Steigenberger Hotel Berlin

Los-Angeles-Platz 1
10789 Berlin

Hotel Booking Link

Accommodation is currently available at the Steigenberger Hotel Berlin at discounted rate. You will receive a link to book your accommodation via once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com).

About the Hotel

The Steigenberger Hotel Berlin is located in the center of the City West – only a 5-minute walk from Kurfürstendamm. The Brandenburg Gate, the Reichstag and Checkpoint Charlie can be reached within 20 to 25 minutes using public transport. You'll be amazed by the outstanding design when you enter any of the 398 rooms and suites. Equipped with air-conditioning, minibar, Nespresso coffee machine, flat-screen TV with Sky and safe: you're sure to enjoy a relaxing stay in Berlin.

For more i
nformation, write to us at: 

Los-Angeles-Platz 1
10789 Berlin
Los-Angeles-Platz 1
10789 Berlin